MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Debt / NOTE 4.500% 7/1
Market price (% of par)
8000.0%
Total 13F principal
$1,000
Principal change
-$48,619,000
Total reported market value
$80,000
Number of holders
1
Value change
-$42,502,000
Number of sells
9

Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q4 2017

As of 31 Dec 2017, MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 was held by 1 institutional bondholder reporting positions in Form 13F filings. These institutions reported holding $1,000 in principal (par value) of the bond. The largest 1 bondholders included UBS Group AG. This page lists 1 institutional bondholders reporting positions for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.